News Servier and Pfizer begin trials for off-the-shelf T-cell can... Companies hope to challenge traiblazers Novartis and Kite.
News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News US drug revenues far exceed R&D spend - report Analysis questions industry's rationale for high US prices.
News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Pfizer's fast-tracked leukaemia candidate could rival CAR-Ts Antibody-drug conjugate with FDA gets six-month review.
News 23andMe study explains variable results with obesity drugs Gene variants could explain why some people lose more weight than others with GLP-1 drugs, and why some are more prone to side effects.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
